P38 mitogen-activated protein kinase inhibition attenuates ischemia-reperfusion injury of the rat liver

被引:114
作者
Kobayashi, M
Takeyoshi, I
Yoshinari, D
Matsumoto, K
Morishita, Y
机构
[1] Gunma Univ, Sch Med, Dept Surg 2, Gunma, Japan
[2] Second Hosp, Nippon Med Sch, Dept Pathol, Kawasaki, Kanagawa, Japan
关键词
D O I
10.1067/msy.2002.121097
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Several studies have implicated the mitogen-activated protein kinase (MAPK) signal pathway in non-hepatic organ ischemia-reperfusion injury. However, the role of p38 MAPK in hepatic ischemia-reperfusion injury remains unclear This study investigated the role pf p38 MAPK in hepatic ischemia-reperfusion injury. Methods. Male Sprague-Dawley, rats were divided into 4 groups (sham, FR-only, control, and FR-treated groups). The animals in the control and FR-treated groups were subjected to 30 minutes of warm ischemia with congestion of the gut. The FR-only and FR-treated groups received FR167653 (FR), which is a novel p38 MAPK inhibitor The serum levels of aspartate transaminase, alanine transaminase, lactate dehydrogenase, tumor necrosis factor-alpha (TNF-alpha), and interleukin-1beta (IL-1beta) were measured (each, n = 6). Liver tissue blood flow was measured at pre-ischemia, end-ischemia, and 30, 60, 90, and 120 minutes after reperfusion (each, n = 4). The liver tissues in the control and FR-treated groups were excised for p38 MAPK and c-Jun N-terminal kinase (JNK) analyses and histopathology (each, n = 4). Results. Serum levels of aspartate transaminase, alanine transaminase, lactate dejydrogenase, TNF-alpha, and IL-1beta were significantly lower in the FR-treated group than in the control group, and liver tissue blood flow was significantly higher in the FR-treated group than in the control go-roup. Histopathologically tissue damage was milder in the FR-treated group than in the control group. Both p38 MAPK and JNK were markedly phosphorylated after 30 minutes of reperfusion, and FR inhibited the phosphorylation of p38 MAPK without affecting the JNK. Conclusions. FR decreased serum TNF-alpha and IL-1beta levels and liver injury associated with the inhibition of p38 MAPK activation. These results suggest that inhibiting the activation of p38 MAPK may attenuate warm ischemia-reperfusion injury of the liver.
引用
收藏
页码:344 / 349
页数:6
相关论文
共 32 条
[1]  
ANDUS T, 1991, HEPATOLOGY, V13, P364, DOI 10.1016/0270-9139(91)92454-G
[2]   Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2 [J].
Ben-Levy, R ;
Hooper, S ;
Wilson, R ;
Paterson, HF ;
Marshall, CJ .
CURRENT BIOLOGY, 1998, 8 (19) :1049-1057
[3]   The MAP kinase cascades are activated during post-ischemic liver reperfusion [J].
Bendinelli, P ;
Piccoletti, R ;
Maroni, P ;
BernelliZazzera, A .
FEBS LETTERS, 1996, 398 (2-3) :193-197
[4]  
BOGOYEVITCH MA, 1995, J BIOL CHEM, V270, P29710
[5]   Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart - p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion [J].
Bogoyevitch, MA ;
GillespieBrown, J ;
Ketterman, AJ ;
Fuller, SJ ;
BenLevy, R ;
Ashworth, A ;
Marshall, CJ ;
Sugden, PH .
CIRCULATION RESEARCH, 1996, 79 (02) :162-173
[6]   Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases [J].
Bradham, CA ;
Stachlewitz, RF ;
Gao, WS ;
Qian, T ;
Jayadev, S ;
Jenkins, G ;
Hannun, Y ;
Lemasters, JJ ;
Thurman, RG ;
Brenner, DA .
HEPATOLOGY, 1997, 25 (05) :1128-1135
[7]   p38 MAPK inhibition decreases TNF-α production and enhances postischemic human myocardial function [J].
Cain, BS ;
Meldrum, DR ;
Meng, XZ ;
Dinarello, CA ;
Shames, BD ;
Banerjee, A ;
Harken, AH .
JOURNAL OF SURGICAL RESEARCH, 1999, 83 (01) :7-12
[8]   Stimulation of "Stress-regulated" mitogen-activated protein kinases (stress-activated protein kinases c-Jun N-terminal kinases and p38-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stresses [J].
Clerk, A ;
Fuller, SJ ;
Michael, A ;
Sugden, PH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (13) :7228-7234
[9]   The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs) [J].
Clerk, A ;
Sugden, PH .
FEBS LETTERS, 1998, 426 (01) :93-96
[10]   SB-203580 IS A SPECIFIC INHIBITOR OF A MAP KINASE HOMOLOG WHICH IS STIMULATED BY CELLULAR STRESSES AND INTERLEUKIN-1 [J].
CUENDA, A ;
ROUSE, J ;
DOZA, YN ;
MEIER, R ;
COHEN, P ;
GALLAGHER, TF ;
YOUNG, PR ;
LEE, JC .
FEBS LETTERS, 1995, 364 (02) :229-233